Review Article

Efficacy and safety of misoprostol for intrauterine device insertion in women with no previous vaginal delivery: a systematic review and meta-analysis of randomized controlled trials

Authors: Ahmad Taher Masoud (Faculty of Medicine, Fayoum University, Fayoum, Egypt) , Ahmed Samy (Department of Obstetrics and Gynaecology, Faculty of Medicine, Cairo University, Egypt) , Hend G Abdelmageed (Faculty of Medicine, Ain Shams University, Cairo, Egypt) , Mai Ibrahim Sokkar (Faculty of Medicine, Menoufia University, Menoufia, Egypt) , Ahmed H Ibrahim (Faculty of Medicine, Ain Shams University, Cairo, Egypt) , Ahmed M Abbas (Department of Obstetrics and Gynaecology, Faculty of Medicine, Assiut University, Egypt) , Ahmed M Afifi (Faculty of Medicine, Ain Shams University, Cairo, Egypt)

  • Efficacy and safety of misoprostol for intrauterine device insertion in women with no previous vaginal delivery: a systematic review and meta-analysis of randomized controlled trials

    Review Article

    Efficacy and safety of misoprostol for intrauterine device insertion in women with no previous vaginal delivery: a systematic review and meta-analysis of randomized controlled trials

    Authors: , , , , , ,

Options

Abstract

Introduction: The efficacy of misoprostol use for cervical priming before intrauterine device insertion (IUD) is controversial. This review aims to evaluate the evidence from published randomized controlled trials about the efficacy and safety of misoprostol before IUD insertion for pain relief in women with no previous vaginal delivery.

Materials and methods: We searched the following electronic databases: Web of Science, Cochrane CENTRAL, SCOPUS, and PubMed for relevant studies using the following Mesh terms: (misoprostol) AND (intrauterine device OR IUD). The primary outcome was the mean pain score during insertion. Secondary outcomes included the ease of insertion score, the rate of successful IUD insertion, the rate of IUD insertion failure, and the adverse effects.

Results: Ten randomized controlled trials (RCTs) (misoprostol: n=698 and placebo: n=689) were pooled in the analysis. The overall Standardized Mean Difference (SMD) of pain score did not favor either of the two groups (SMD= -0.09, 95%CI [-0.50, 0.33], p=0.007). Pooled results were highly heterogeneous (I2=93%, P<0.001). The total MD of the ease of insertion score favored the misoprostol group (MD= -1.36, 95% CI [-2.20, -0.52], p =0.002). The overall risk ratio (RR) of the number of failed insertions showed that misoprostol is associated with less IUD insertion failures compared to placebo (RR=0.55, 95% CI [0.38, 0.81], p=0.002). Finally, the overall risk showed that misoprostol is associated with more shivering, diarrhea and pelvic pain.

Conclusions: Misoprostol facilitates IUD insertion in women with no previous vaginal delivery, and is associated with 50% less chance for IUD insertion failure despite inducing mild adverse effects

Keywords: Intrauterine device; misoprostol; vaginal delivery; contraception; efficacy

How to Cite:

Masoud, A. T. & Samy, A. & Abdelmageed, H. G. & Sokkar, M. I. & Ibrahim, A. H. & Abbas, A. M. & Afifi, A. M., (2020) “Efficacy and safety of misoprostol for intrauterine device insertion in women with no previous vaginal delivery: a systematic review and meta-analysis of randomized controlled trials”, Proceedings in Obstetrics and Gynecology 10(1), 1-20. doi: https://doi.org/10.17077/2154-4751.1479

Rights: Copyright © 2020 the authors

Downloads:
Download pdf
View PDF

1114 Views

117 Downloads

Published on
01 Nov 2020
Peer Reviewed
License
CC BY 4.0